Discover 1,289 paid clinical trials in Columbus, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Columbus hosts a variety of active clinical studies, including for conditions such as diabetes, asthma, and cardiovascular diseases. The city's prominent healthcare institutions are recruiting participants, both as healthy volunteers seeking paid research opportunities and individuals in need of trials for specific conditions, offering access to new and innovative treatments and therapies.
Filter
2
Filter results
Results: 1,289
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
Location: Columbus OH, Detroit MI, Baltimore MD, Madison WI,
Sponsor: TopAlliance Biosciences
Sex: All
Age: 18+
Code: NCT04137900
Phase1, Recruiting
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
for
Carcinoma, Non-Small-Cell Lung
Location: Columbus OH, Philadelphia PA, Lebanon NH,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT04165070
Phase1, Phase2, Recruiting
Third Party Viral Specific T-cells (VSTs)
for
Viral Infection, Viral Reactivation,
Location: Columbus OH, Cincinnati OH, Akron OH
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 0+
Code: NCT02532452
Phase2, Recruiting
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
for
Epithelial Ovarian Cancer, Primary Peritoneal,
Location: Columbus OH, Chicago IL, Toronto, Annapolis MD,
Sponsor: TORL Biotherapeutics, LLC
Sex: Female
Age: 18+
Code: NCT06690775
Phase2, Recruiting
Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling
for
HER2-negative Breast Cancer
Location: Columbus OH, Delaware OH, Newark OH, Mount Vernon OH,
Sponsor: NSABP Foundation Inc
Sex: Female
Age: 18+
Code: NCT03412643
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Location: Columbus OH, Cleveland OH, Louisville KY, Ann Arbor MI,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT05735184
Phase1, Recruiting
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
for
HIV Infection, Tobacco-Related Carcinoma
Location: Columbus OH, Washington D.C. DC, St Louis MO,
Sponsor: AIDS Malignancy Consortium
Sex: All
Age: 45 - 70+
Code: NCT04949464
Recruiting
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
for
Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC)
Location: Columbus OH, Cleveland OH, Detroit MI, Louisville KY,
Sponsor: J-Pharma Co., Ltd.
Sex: All
Age: 18+
Code: NCT07265674
Phase3, Recruiting
Ziftomenib Maintenance Post Allo-HCT
for
Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission,
Location: Columbus OH, Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT06440135
Phase1, Recruiting
Computer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or Weight Control
for
Melanoma (Skin), Non-melanomatous Skin Cancer
Location: Columbus OH, Philadelphia PA, Providence RI, Wichita KS,
Sponsor: Rhode Island Hospital
Sex: All
Age: 18+
Code: NCT00295906
Recruiting
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
for
Relapsed/Refractory B-cell Malignancies
Location: Columbus OH, Cleveland OH, Chapel Hill NC, Sarasota FL,
Sponsor: Accutar Biotechnology Inc
Sex: All
Age: 18+
Code: NCT05780034
Phase1, Recruiting
Study of SGR-1505 in Mature B-Cell Neoplasms
for
Mature B-Cell Neoplasm, Non Hodgkin Lymphoma, DLBCL,
Location: Columbus OH, Canton OH, Buffalo NY, Milwaukee WI,
Sponsor: Schrödinger, Inc.
Sex: All
Age: 18+
Code: NCT05544019
Phase1, Recruiting
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Columbus OH, Louisville KY, Atlanta GA, New York NY,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT03761108
Phase1, Phase2, Recruiting
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
for
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer